Elanco Animal Health's EBITDA rose 149.25% to $167.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year increase of 105.29%. This contributed to the annual value of -$1.5 billion for FY2024, which is 51.54% up from last year.
Latest data reveals that Elanco Animal Health reported EBITDA of $167.0 million as of Q3 2025, which was down 24.43% from $221.0 million recorded in Q2 2025.
In the past 5 years, Elanco Animal Health's EBITDA registered a high of $249.0 million during Q1 2025, and its lowest value of -$1.6 billion during Q3 2023.
Moreover, its 3-year median value for EBITDA was -$503.0 million (2024), whereas its average is -$364.0 million.
As far as peak fluctuations go, Elanco Animal Health's EBITDA crashed by 206.98% in 2023, and later surged by 149.50% in 2025.
Elanco Animal Health's EBITDA (Quarterly) stood at -$635.0 million in 2021, then increased by 15.43% to -$537.0 million in 2022, then declined by 19.74% to -$643.0 million in 2023, then grew by 14.15% to -$552.0 million in 2024, then skyrocketed by 149.25% to $167.0 million in 2025.
Its EBITDA stands at $167.0 million for Q3 2025, versus $221.0 million for Q2 2025 and $249.0 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value